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PAST DECADE AT THE JIKEI UNIVERSITY HOSPITAL 
Isao IKEMoTo， Tatsuya SHIMOMURA， Hiroki YAMADA， Takahiro KIMURA， 
Taro HASEGAWA， Kazuhiro ABE and Yukihiko OISHI 
From the Depart仰 nt01 Urology， Jikei University School 01 Medicine 
The aim of this study was to investigate recent characteristics and alterations of upper urinary 
tract cancer based on experience at a single institution over the past decade. 
Ninety-nine patients with renal pelvic and ureteral cancer resected at theJikei University Hospital 
from Januarγ1991 through December 2000 were retrospectively analyzed. Cancer-specific survival 
by pathologic stage， grade， and various clinical parameters were calculated by the Kaplan-Meier 
method. Prognostic factors for survival were examined with univariate and multivariate analysis. 
Cox regression analysis was used for multivariate analysis. 
Twenty-eight percent of cancers had been detected incidentally without having caused any 
symptoms. The overall 3・yearand 5・yearcance.r-specific survival rates were 78% and 70%， 
respectively. The 5-year survival rate was 100% in patients with G 1 cancer and 38% in those with G3 
cancer. The 5ヴearsurvival rate was significantly higher in patients with cancers oflower grade (p= 
0.0089)， and was also higher in patients with cancers of stage pTl or lower than in patients with cancers 
of stage pT2 and higher (p=0.0038). The survival of patients with recurrence in the bladder was 
significantly longer than that of patients with recurrence in other organs. Multivariate analysis 
indicated that patient age and pT were the most important prognostic factors， followed by the presence 
of symptoms at diagnosis. 
The incidence of asymptomatic upper urinary tract cancer is increasing at institutions in ]apan. 
We conclude that the cancer grade and stage stil have classical predictive value， but that the presence 
of symptoms at the time of diagnosis is also an important prognostic factor. 
(Acta Urol. ]pn. 49: 451-456， 2003) 
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果 class1が l例;class 1が21例， class 111が29例，
class IVが13例， class Vが23例，不明13例であっ
た.したがって細胞診施行例の74.7%が疑陽性または
陽性であった.
Table 1. Patient characteristics 
主訴 自覚症状のあった群 自覚症状のなかった群
肉眼的血尿 60例 顕微鏡的血尿 12例
腹痛 6例 尿中異型細胞出現 5例
排尿痛 l例 ドック ECHO異常 3例
腰痛 1例 健診 ECHO異常 3例
勝脱癌経過観察 3例 その他








病理 TCC 89例 TCC+SCC 6例 SCC 2例

















(SCC)が6例， SCC 2例，未分化癌 1例，そして
TCCおよび腺癌 l例であった.組織学的異型度は
Gl 6例， G252例， G339例，不明 l例であった.組
織学的深達度は pTl以下が41例 (pTl18例， pTis 2 
例， pTa 15例)， pT2が15例， pT339例， pT44例
であった.












































Fig. 1. Cause-specific survival in al patients and according 
to T stage. 
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Fig. 3. Cause-specific survival according to symptom in-
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Fig. 4. Cause司specificsurvival in patients with or without 
bladder recurrence. 
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Fig. 5. Cause-specific survival in advanced pa-
tients (>G2， T2) with or without a司juvant
chemotherapy composed by MEC (or M-
VAC). 
Table 2. Comparison of patient characteristics with or without adjuvant chemotherapy 
Sex Chief complaint Location Side Grade Stage 
Case Age 
Female h!!aa~~;ia Others Pelvis Ureter Lt Rt G3 G2 1-~ T2 Male 
Group with ad- 27 65士1 15 12 15 12 18 9 16 1 12 15 25 5 Juvant 
Group without 25 61土12 17 6 12 1 10 13 15 8 16 7 14 9 adjuvant 
Table 3. Analysis by Cox's proportional p=O.O判4とp=O.0367)を認め，また初診時の自覚
hazard model (multiple variables) 症状の有無も重要な予後因子 (p=O.0536)であった.
Risk 95% CI 
vz;ie Variable Ratio 考 察Lower Upper 
年齢 -64/65- 2.777 1.026 7.515 0.0付4 われわれは最近10年間に l施設としては多数の腎孟
細胞診 cIass-2/3- 0.825 0.276 2.47 0.7316 尿管癌を経験し，一部の症例では経皮的内視鏡切除な
組織型 TCC/other 0.989 0.283 3.449 0.9857 
どの先進的試みを行ったものの，今回提示した99例で
異型度 radel+2/ 2.462 0.781 7.758 0.1239 は従来の標準的治療である開腹による腎尿管全摘術を
深遠度 -pTl/pT2- 5.303 1. 109 25.359 0.0367 中心とした外科療法と最近数年は進行例に対し積極的
所パ属節リ、;/ pNO/pNI- 2.300 0.800 6.606 0.1219 に術後の全身化学療法を行ってきた.そこでこれまで
主訴(症鑑有 3.246 0.933 12.434 0.0536 本邦で報告されている数多くの retrospectiveな臨床状)/
統計学的観察と今回の最近10年間のわれわれの結果を
部位 pelvis/ ure- 0.641 0.234 1.752 0，3857 比較検討し，近年における本邦での腎孟尿管癌の特徴ter 
(n=84) と変貌について考察したい.

















































いがある.われわれは今回 MEC療法を24例， MVAC 
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